These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 12227693

  • 1. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
    Rauta V, Finne P, Fagerudd J, Rosenlöf K, Törnroth T, Grönhagen-Riska C.
    Clin Nephrol; 2002 Aug; 58(2):85-94. PubMed ID: 12227693
    [Abstract] [Full Text] [Related]

  • 2. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K.
    Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155
    [Abstract] [Full Text] [Related]

  • 3. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H.
    Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
    [Abstract] [Full Text] [Related]

  • 4. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
    Shi X, Chen X, Liu S, Zhuang Y, Zhang Y.
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
    [Abstract] [Full Text] [Related]

  • 5. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of IgA nephropathy in advanced-age patients.
    Oshima Y, Moriyama T, Itabashi M, Takei T, Nitta K.
    Int Urol Nephrol; 2015 Jan; 47(1):137-45. PubMed ID: 25388352
    [Abstract] [Full Text] [Related]

  • 7. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B, John GT, Neelakantan N, Korula A, Balakrishnan N, Kirubakaran MG, Jacob CK.
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [Abstract] [Full Text] [Related]

  • 8. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.
    Am J Nephrol; 2015 Oct; 41(3):210-9. PubMed ID: 25872002
    [Abstract] [Full Text] [Related]

  • 9. The retrospective analysis of 343 Czech patients with IgA nephropathy--one centre experience.
    Maixnerova D, Bauerova L, Skibova J, Rysava R, Reiterova J, Merta M, Honsova E, Tesar V.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1492-8. PubMed ID: 21891776
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury.
    Zhang L, Li J, Yang S, Huang N, Zhou Q, Yang Q, Yu X.
    Ren Fail; 2016 Jun; 38(5):799-805. PubMed ID: 27050722
    [Abstract] [Full Text] [Related]

  • 11. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2017 Jun; 955():65-73. PubMed ID: 27718216
    [Abstract] [Full Text] [Related]

  • 12. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 13. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Jun 06; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 14. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Yu GZ, Guo L, Dong JF, Shi SF, Liu LJ, Wang JW, Sui GL, Zhou XJ, Xing Y, Li HX, Lv JC, Zhang H.
    Am J Kidney Dis; 2020 Jul 06; 76(1):90-99. PubMed ID: 32197881
    [Abstract] [Full Text] [Related]

  • 15. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
    Pesce F, Diciolla M, Binetti G, Naso D, Ostuni VC, Di Noia T, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Di Sciascio E, Schena FP.
    Nephrol Dial Transplant; 2016 Jan 06; 31(1):80-6. PubMed ID: 26047632
    [Abstract] [Full Text] [Related]

  • 16. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 06; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 17. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury].
    Chen MG, Ye XH, Liang HY, Yang Q.
    Zhonghua Er Ke Za Zhi; 2016 Aug 06; 54(8):610-3. PubMed ID: 27510875
    [Abstract] [Full Text] [Related]

  • 18. Primary IgA nephropathy in elderly patients.
    Cheungpasitporn W, Nasr SH, Thongprayoon C, Mao MA, Qian Q.
    Nephrology (Carlton); 2015 Jun 06; 20(6):419-25. PubMed ID: 25726845
    [Abstract] [Full Text] [Related]

  • 19. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.
    Nephrol Dial Transplant; 2012 May 06; 27(5):1916-23. PubMed ID: 21940483
    [Abstract] [Full Text] [Related]

  • 20. Clinical and histopathological spectrum of IgA nephropathy in Kuwait.
    Ghani AA, Al Waheeb S, Al Homoud E, Al Helal B, Hussain N.
    Ann Saudi Med; 2011 May 06; 31(2):152-7. PubMed ID: 21403411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.